NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.8200
-0.0398 (-4.63%)
Aug 14, 2025, 11:30 AM - Market open
NMTC Revenue
NeuroOne Medical Technologies had revenue of $1.39M in the quarter ending March 31, 2025, with 0.67% growth. This brings the company's revenue in the last twelve months to $5.76M, up 54.53% year-over-year. In the fiscal year ending September 30, 2024, NeuroOne Medical Technologies had annual revenue of $3.45M with 1.33% growth.
Revenue (ttm)
$5.76M
Revenue Growth
+54.53%
P/S Ratio
4.45
Revenue / Employee
$338,752
Employees
17
Market Cap
40.85M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
Sep 30, 2020 | 1.93M | - | - |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
NMTC News
- 1 hour ago - NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 hours ago - NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% - GlobeNewsWire
- 13 days ago - NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update - GlobeNewsWire
- 14 days ago - NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - GlobeNewsWire
- 22 days ago - NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office - GlobeNewsWire
- 7 weeks ago - NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System - GlobeNewsWire
- 2 months ago - NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary - GlobeNewsWire
- 2 months ago - NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025 - GlobeNewsWire